75P Patient-reported outcomes (PROs) of cemiplimab + chemotherapy in advanced non-small cell lung cancer (NSCLC): EMPOWER-lung 3 liver metastases subpopulation
| Autor: | Baramidze, A., Gessner, C., Gogishvili, M., Sezer, A., Makharadze, T., Kilickap, S., Gumus, M., He, X., Gullo, G., Rietschel, P., Quek, R. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|